Perspective on schistosomiasis drug discovery: Highlights from a schistosomiasis drug discovery workshop at Wellcome Collection, London, September 2022
Comparison of the macrofilaricidal efficacy of oxfendazole and its isomers against the rodent filaria Litomosoides sigmodontis
Discovery of substituted di(pyridin-2-yl)-1,2,4-thiadiazol-5-amines as novel macrofilaricidal compounds for the treatment of human filarial infections
Filarial nematode phenotypic screening cascade to identify compounds with anti-parasitic activity for drug discovery optimization